Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
CDK7 CAK, CAK1, CDKN7, MO15, STK1
Sequence Length (AA) Molecular Weight (Da)
346 39038
Protein Name
Cyclin-dependent kinase 7
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MALDVKSRAK RYEKLDFLGE GQFATVYKAR DKNTNQIVAI KKIKLGHRSE
60 70 80 90 100
AKDGINRTAL REIKLLQELS HPNIIGLLDA FGHKSNISLV FDFMETDLEV
110 120 130 140 150
IIKDNSLVLT PSHIKAYMLM TLQGLEYLHQ HWILHRDLKP NNLLLDENGV
160 170 180 190 200
LKLADFGLAK SFGSPNRAYT HQVVTRWYRA PELLFGARMY GVGVDMWAVG
210 220 230 240 250
CILAELLLRV PFLPGDSDLD QLTRIFETLG TPTEEQWPDM CSLPDYVTFK
260 270 280 290 300
SFPGIPLHHI FSAAGDDLLD LIQGLFLFNP CARITATQAL KMKYFSNRPG
310 320 330 340 346
PTPGCQLPRP NCPVETLKEQ SNPALAIKRK RTEALEQGGL PKKLIF

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-5912 Collapse assay details

Data source: Panorama

Official Gene Symbol
CDK7
Peptide Modified Sequence
AYT[+79.966331]HQVVTR
Modification Type
Phospho (ST)
Protein - Site of Modification
171
Peptide - Site of Modification
3
Peptide Start
168
Peptide End
176
CPTAC ID
CPTAC-5912
Peptide Molecular Mass
1,153.5281
Species
Homo sapiens (Human)
Assay Type
Enrichment PRM
Enrichment Method
N/A
Matrix
Cell Lysate
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Sciex 5500 QTRAP
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Eksigent 425
Column Packing
Reprosil
Column Dimensions
75um x 15cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y7-98 (2+) 19 9 9.4 23.3 9.6 9 30.1 13.2 13 15 27 15
y7 (2+) 37.5 18.5 12.3 38.2 16.4 13.7 53.5 24.7 18.4 15 27 15
y4 (1+) 20.6 10.6 9.3 33.4 19.2 13.1 39.2 21.9 16.1 15 27 15
y3 (1+) 14.9 11 7.3 23.2 18 9.6 27.6 21.1 12.1 15 27 15
y2 (1+) 33.1 14.7 12.4 28.6 16.9 19.6 43.7 22.4 23.2 15 27 15
y8 (2+) 28.5 24.2 12.3 33.8 20.3 20.8 44.2 31.6 24.2 15 27 15
y8-98 (2+) 19.9 10.4 8.2 19.8 13.2 7.5 28.1 16.8 11.1 15 27 15
sum 12 5.6 4.1 14.7 9.7 5.8 19 11.2 7.1 15 27 15


Additional Resources and Comments


Assay Details for CPTAC-3036 Collapse assay details

Data source: Panorama

Official Gene Symbol
CDK7
Peptide Sequence
LDFLGEGQFATVYK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
15
Peptide End
28
CPTAC ID
CPTAC-3036
Peptide Molecular Mass
1,586.7981
Species
Homo Sapiens
Assay Type
Direct PRM
Matrix
Tumor Digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
ThermoFisher, Q-Exactive
Internal Standard
25 fmol on column
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Easy-nLC 1000 Thermo Scientific
Column Packing
C18
Column Dimensions
75 µm x 50 cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (1+) 9.2 4.4 4.5 10.2 6.9 5.1 13.7 8.2 6.8 15 15 15
y10 (1+) 5.6 4.1 4.5 5.7 7.5 4.9 8 8.5 6.7 15 15 15
b3 (1+) 5.7 2.5 3.5 6.5 4.8 4.2 8.6 5.4 5.5 15 15 15
sum 6 3.4 4 6.3 6.3 4.6 8.7 7.2 6.1 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-3037 Collapse assay details

Data source: Panorama

Official Gene Symbol
CDK7
Peptide Sequence
NTNQIVAIK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
33
Peptide End
41
CPTAC ID
CPTAC-3037
Peptide Molecular Mass
999.5713
Species
Homo Sapiens
Assay Type
Direct PRM
Matrix
Tumor Digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
ThermoFisher, Q-Exactive
Internal Standard
25 fmol on column
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Easy-nLC 1000 Thermo Scientific
Column Packing
C18
Column Dimensions
75 µm x 50 cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y3 (1+) 4.7 6.1 5.7 5.3 6.9 6.9 7.1 9.2 8.9 15 15 15
y4 (1+) 3.8 4.7 5.7 3.8 6.1 7.8 5.4 7.7 9.7 15 15 15
y7 (1+) 5.6 4.4 4.9 6.2 5.9 6.7 8.4 7.4 8.3 15 15 15
sum 3.8 4.9 5.2 4.5 6 6.6 5.9 7.7 8.4 15 15 15


Additional Resources and Comments